Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam
Elsevier/Academic Press
©2010
|
| Schriftenreihe: | International review of neurobiology
v. 95 |
| Schlagworte: | |
| Online-Zugang: | FAW01 Volltext |
| Beschreibung: | "Since its discovery in 1958, the Catechol-O-methyltransferase (COMT) enzyme has generated a lot of excitement, particularly so in more recent years with the discovery of clinically relevant COMT inhibitors in the late 1980's. While the volume of published research on the COMT enzyme and its inhibitors is substantial, there is no comprehensive, up-to-date source containing all the information available on basic COMT biochemistry and pharmacology, as well as critical review of results from clinical trials. This volume of International Review of Neurobiology summarizes what is currently known about COMT enzyme: its genomics, structure, function and biochemical properties; and presents up-to-date evaluation of the clinical use of COMT inhibitors as an adjunct to levodopa/dopa decarboxylase inhibitor treatment in Parkinson's disease."--Publisher's description Includes bibliographical references and index |
| Beschreibung: | xii, 323 pages |
| ISBN: | 9780123813275 0123813271 9780123813268 0123813263 1282954881 9781282954885 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044387604 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170630s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 9780123813275 |9 978-0-12-381327-5 | ||
| 020 | |a 0123813271 |9 0-12-381327-1 | ||
| 020 | |a 9780123813268 |9 978-0-12-381326-8 | ||
| 020 | |a 0123813263 |9 0-12-381326-3 | ||
| 020 | |a 1282954881 |9 1-282-95488-1 | ||
| 020 | |a 9781282954885 |9 978-1-282-95488-5 | ||
| 035 | |a (ZDB-33-ESD)ocn702118872 | ||
| 035 | |a (OCoLC)702118872 | ||
| 035 | |a (DE-599)BVBBV044387604 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615.788 |2 22 | |
| 245 | 1 | 0 | |a Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors |c edited by Erkki Nissinen |
| 264 | 1 | |a Amsterdam |b Elsevier/Academic Press |c ©2010 | |
| 300 | |a xii, 323 pages | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a International review of neurobiology |v v. 95 | |
| 500 | |a "Since its discovery in 1958, the Catechol-O-methyltransferase (COMT) enzyme has generated a lot of excitement, particularly so in more recent years with the discovery of clinically relevant COMT inhibitors in the late 1980's. While the volume of published research on the COMT enzyme and its inhibitors is substantial, there is no comprehensive, up-to-date source containing all the information available on basic COMT biochemistry and pharmacology, as well as critical review of results from clinical trials. This volume of International Review of Neurobiology summarizes what is currently known about COMT enzyme: its genomics, structure, function and biochemical properties; and presents up-to-date evaluation of the clinical use of COMT inhibitors as an adjunct to levodopa/dopa decarboxylase inhibitor treatment in Parkinson's disease."--Publisher's description | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 7 | |a MEDICAL / Pain Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Psychiatry / Psychopharmacology |2 bisacsh | |
| 650 | 7 | |a Catecholamines |2 fast | |
| 650 | 7 | |a Parkinson's disease / Chemotherapy |2 fast | |
| 650 | 7 | |a Psychotropic drugs |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Catecholamines | |
| 650 | 4 | |a Psychotropic drugs | |
| 650 | 4 | |a Parkinson's disease |x Chemotherapy | |
| 700 | 1 | |a Nissinen, Erkki |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/bookseries/00747742/95 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029789825 | ||
| 966 | e | |u http://www.sciencedirect.com/science/bookseries/00747742/95 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804177656816599040 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044387604 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (ZDB-33-ESD)ocn702118872 (OCoLC)702118872 (DE-599)BVBBV044387604 |
| dewey-full | 615.788 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.788 |
| dewey-search | 615.788 |
| dewey-sort | 3615.788 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02774nmm a2200517zcb4500</leader><controlfield tag="001">BV044387604</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170630s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780123813275</subfield><subfield code="9">978-0-12-381327-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123813271</subfield><subfield code="9">0-12-381327-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780123813268</subfield><subfield code="9">978-0-12-381326-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123813263</subfield><subfield code="9">0-12-381326-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282954881</subfield><subfield code="9">1-282-95488-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282954885</subfield><subfield code="9">978-1-282-95488-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)ocn702118872</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)702118872</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044387604</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.788</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors</subfield><subfield code="c">edited by Erkki Nissinen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Elsevier/Academic Press</subfield><subfield code="c">©2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xii, 323 pages</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">International review of neurobiology</subfield><subfield code="v">v. 95</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Since its discovery in 1958, the Catechol-O-methyltransferase (COMT) enzyme has generated a lot of excitement, particularly so in more recent years with the discovery of clinically relevant COMT inhibitors in the late 1980's. While the volume of published research on the COMT enzyme and its inhibitors is substantial, there is no comprehensive, up-to-date source containing all the information available on basic COMT biochemistry and pharmacology, as well as critical review of results from clinical trials. This volume of International Review of Neurobiology summarizes what is currently known about COMT enzyme: its genomics, structure, function and biochemical properties; and presents up-to-date evaluation of the clinical use of COMT inhibitors as an adjunct to levodopa/dopa decarboxylase inhibitor treatment in Parkinson's disease."--Publisher's description</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pain Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Psychiatry / Psychopharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Catecholamines</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Parkinson's disease / Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychotropic drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Catecholamines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson's disease</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nissinen, Erkki</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/bookseries/00747742/95</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029789825</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/bookseries/00747742/95</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044387604 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:51:33Z |
| institution | BVB |
| isbn | 9780123813275 0123813271 9780123813268 0123813263 1282954881 9781282954885 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029789825 |
| oclc_num | 702118872 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | xii, 323 pages |
| psigel | ZDB-33-ESD ZDB-33-EBS ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Elsevier/Academic Press |
| record_format | marc |
| series2 | International review of neurobiology |
| spelling | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors edited by Erkki Nissinen Amsterdam Elsevier/Academic Press ©2010 xii, 323 pages txt rdacontent c rdamedia cr rdacarrier International review of neurobiology v. 95 "Since its discovery in 1958, the Catechol-O-methyltransferase (COMT) enzyme has generated a lot of excitement, particularly so in more recent years with the discovery of clinically relevant COMT inhibitors in the late 1980's. While the volume of published research on the COMT enzyme and its inhibitors is substantial, there is no comprehensive, up-to-date source containing all the information available on basic COMT biochemistry and pharmacology, as well as critical review of results from clinical trials. This volume of International Review of Neurobiology summarizes what is currently known about COMT enzyme: its genomics, structure, function and biochemical properties; and presents up-to-date evaluation of the clinical use of COMT inhibitors as an adjunct to levodopa/dopa decarboxylase inhibitor treatment in Parkinson's disease."--Publisher's description Includes bibliographical references and index MEDICAL / Pain Medicine bisacsh MEDICAL / Psychiatry / Psychopharmacology bisacsh Catecholamines fast Parkinson's disease / Chemotherapy fast Psychotropic drugs fast Medizin Catecholamines Psychotropic drugs Parkinson's disease Chemotherapy Nissinen, Erkki Sonstige oth http://www.sciencedirect.com/science/bookseries/00747742/95 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors MEDICAL / Pain Medicine bisacsh MEDICAL / Psychiatry / Psychopharmacology bisacsh Catecholamines fast Parkinson's disease / Chemotherapy fast Psychotropic drugs fast Medizin Catecholamines Psychotropic drugs Parkinson's disease Chemotherapy |
| title | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors |
| title_auth | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors |
| title_exact_search | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors |
| title_full | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors edited by Erkki Nissinen |
| title_fullStr | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors edited by Erkki Nissinen |
| title_full_unstemmed | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors edited by Erkki Nissinen |
| title_short | Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors |
| title_sort | basic aspects of catechol o methyltransferase and the clinical applications of its inhibitors |
| topic | MEDICAL / Pain Medicine bisacsh MEDICAL / Psychiatry / Psychopharmacology bisacsh Catecholamines fast Parkinson's disease / Chemotherapy fast Psychotropic drugs fast Medizin Catecholamines Psychotropic drugs Parkinson's disease Chemotherapy |
| topic_facet | MEDICAL / Pain Medicine MEDICAL / Psychiatry / Psychopharmacology Catecholamines Parkinson's disease / Chemotherapy Psychotropic drugs Medizin Parkinson's disease Chemotherapy |
| url | http://www.sciencedirect.com/science/bookseries/00747742/95 |
| work_keys_str_mv | AT nissinenerkki basicaspectsofcatecholomethyltransferaseandtheclinicalapplicationsofitsinhibitors |